While the precise mechanisms by which these signaling pathways influence immunity remain to be fully elucidated, our observations provide new hypotheses for how tumor cells may communicate with antitumor T cells through MIF–CD74 and HLA-E–NKG2A, potentially contributing to cytotoxic dysfunction. This evidence concerns the gene CD74 and neoplasm.